A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States

By sjmartinez • March 22, 2023

Pathoulas JT, Flanagan KE, Walker CJ, Collins MS, Ali S, Pupo Wiss IM, Cotsarelis G, Milbar H, Huang K, Mostaghimi A, Scott D, Han JJ, Lee KJ, Hordinsky MK, Farah RS, Bellefeuille G, Raymond O, Bergfeld W, Ranasinghe G, Shapiro J, Lo Sicco KI, Gutierrez D, Ko J, Mirmirani P, Mesinkovska N, Yale KL, Goldberg LJ, Tosti A, Gwillim EC, Goh C, Senna MM. A multicenter descriptive analysis of 270 men with frontal fibrosing alopecia and lichen planopilaris in the United States. J Am Acad Dermatol. 2023 Apr;88(4):937-939. doi: 10.1016/j.jaad.2022.10.060. Epub 2022 Nov 15. PMID: 36396001.

Tags: AGA, Alopecia, androgenetic alopecia, autoimmune, beard loss, body hair, cicatricial, cicatricial alopecia, Dermatology, dermatology, eyebrows, facial hair, FFA, fibrosing, fibrosis, frontal fibrosing alopecia, hair, hair loss, hair loss in men, hair specialists, itch, lichen planopilaris, loss, LPP, male pattern hair loss, men, misdiagnosis, MPHL, multicenter, pattern hair loss, PHL, pruritus, Publications, retrospective review, scalp itch, scalp symptoms, scarring, scarring alopecia, sideburns, specialty hair clinic, sunscreen

Biological Aging in Combination with Lifestyle Factors in the Blood-Based Methylome: A Biomarker for Colorectal Cancer Susceptibility in African American Women

Jung SY, Pellegrini M, Yu H. Biological Aging in Combination with Lifestyle Factors in the Blood-Based Methylome: A Biomarker for Colorectal Cancer Susceptibility in African[...]

Treatment of Solar Lentigines: A Systematic Review of Clinical Trials

Mardani G, Nasiri MJ, Namazi N, Farshchian M, Abdollahimajd F. Treatment of Solar Lentigines: A Systematic Review of Clinical Trials. J Cosmet Dermatol. 2025 Apr;24(4):e70133.[...]

Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials

Armstrong AW, Kircik L, Stein Gold L, Strober B, De Oliveira CHMC, Vaile J, Jou YM, Daamen C, Scharnitz T, Lebwohl M. Deucravacitinib: Laboratory Parameters[...]